id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1999-N-0134-0122,FDA,FDA-1999-N-0134,NACMF,Other,TS-Testimony,2008-11-18T05:00:00Z,2008,11,2008-11-18T05:00:00Z,,2008-11-18T20:43:51Z,,0,0,09000064804aeb82
FDA-1999-N-0134-0124,FDA,FDA-1999-N-0134,"Transcript - Sept 23, 1999 meeting",Other,TR-Transcript,2008-11-18T05:00:00Z,2008,11,2008-11-18T05:00:00Z,,2008-11-18T22:39:53Z,,0,0,09000064804aeb8a
FDA-1999-N-0134-0123,FDA,FDA-1999-N-0134,"Transcript - May 27, 1999 Meeting",Other,TR-Transcript,2008-11-18T05:00:00Z,2008,11,2008-11-18T05:00:00Z,,2008-11-18T21:37:55Z,,0,0,09000064804aeb86